Antisense oligonucleotides: is the glass half full or half empty?

Area of Science:

• Molecular Biology
• Pharmacology
• Drug Discovery

Background:

• Antisense oligonucleotides (ASOs) are valuable tools for studying gene function by inhibiting gene product expression.
• ASOs are being explored for therapeutic applications in viral infections, cancer, and inflammatory diseases.

Purpose of the Study:

• To address the challenge of confirming the specific antisense mechanism of action for oligonucleotides.
• To highlight the importance of rigorous experimentation in validating oligonucleotide efficacy.

Main Methods:

• Investigating sequence-dependent and -independent interactions of oligonucleotides with proteins.
• Demonstrating RNA binding and selective gene product reduction by ASOs in cellular and tissue models.
• Employing a selection process to identify potent and selective ASO inhibitors targeting specific RNA regions.

Main Results:

• Oligonucleotides can interact with proteins in both sequence-dependent and -independent ways.
• Successful demonstration of ASOs binding to target RNA, leading to reduced gene product levels and pharmacological effects.
• Identification of potent and selective ASOs through rigorous screening and evaluation.

Conclusions:

• Careful experimental design, including proper controls and dose-response studies, is essential for validating ASO activity.
• Despite potential off-target effects, ASOs can be effectively utilized as research tools.
• Optimized ASOs hold promise as therapeutic agents for various diseases.